Protagonist Therapeutics (PTGX) net assets (shareholders' equity)

Net assets · fiscal 2025
$614.71M

Protagonist Therapeutics (PTGX) had net assets of $614.71M at the end of fiscal 2025 (December 31, 2025). That is 9.0% lower than the $675.30M of fiscal 2024. Figures as of 19 Nov 2026, 11:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$614.71M
Change on fiscal 2024
−9.0%
Growth, 5 years
+17.1% a year
Highest on record
$675.30Mfiscal 2024
Lowest on record
-$27.40Mfiscal 2015
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Protagonist Therapeutics net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 17.1% a year. Across the 12 fiscal years on record (2014–2025), the highest was $675.30M in fiscal 2024 and the lowest -$27.40M in fiscal 2015.

History · 12 fiscal years

Net assets by fiscal year

Protagonist Therapeutics net assets (shareholders' equity), year by year

Protagonist Therapeutics (PTGX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$614.71M 9.0% down
2024$675.30M 100.6% up
2023$336.68M 56.2% up
2022$215.61M 28.1% down
2021$300.02M 7.3% up
2020$279.61M 249.7% up
2019$79.96M 28.9% down
2018$112.52M 6.7% down
2017$120.63M 37.8% up
2016$87.56M—
2015-$27.40M—
2014-$12.62M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on PTGX

Protagonist Therapeutics, figure by figure

Protagonist Therapeutics (PTGX) overview: price, valuation and scorecardAll health care companies by market value

Protagonist Therapeutics net assets (shareholders' equity): questions and answers

What are Protagonist Therapeutics's net assets?

Protagonist Therapeutics (PTGX) had net assets of $614.71M at the end of fiscal 2025 (December 31, 2025). That is 9.0% lower than the $675.30M of fiscal 2024.

What is the growth rate of Protagonist Therapeutics's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 17.1% a year.

What are the highest and lowest net assets figures on record for Protagonist Therapeutics?

Across the 12 fiscal years on record (2014–2025), the highest was $675.30M in fiscal 2024 and the lowest -$27.40M in fiscal 2015.

How is Protagonist Therapeutics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Protagonist Therapeutics it is on record here for 12 fiscal years, 2014 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Protagonist Therapeutics (PTGX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/PTGX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.